China began clinical trials for a vaccine designed specifically against the Omicron variant in Hangzhou, Zhejiang province, on Sunday, making it the first vaccine of its kind to enter human trials in the world against the highly transmissible COVID-19 strain.
选项:
A:statistics;
B:comparison;
C:definition;
D:illustration
发布时间:2024-05-11 08:09:51